US declares support for patent waiver on Covid-19 vaccines
theguardian.com
theguardian.com
- this was not done without some level of agreement from the companies affected
- other companies can use the IP, if they can make it work (major challenge with the mRNA vaccines)
- for the mRNA vaccines this will have little to no impact; other companies can use the IP but it will take a year or more before they can start producing vaccines, and by then we’ll be onto v2.0
- the IP holders will enter into licensing agreements before any IP is broken (in exchange for technical help). Companies won’t miss out on much revenue since these werent priority markets anyways
Basically the manufacturers will keep the wealthy western markets to themselves where all the profit is while gaining PR by opening up more access for developing countries
https://pbs.twimg.com/media/EuiX6-dXMAIsT7_?format=jpg&name=...